Evidence map›Paper›PMID 25485905›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2015

Elevated pressure causes endothelial dysfunction in mouse carotid arteries by increasing local angiotensin signaling.

Yingzi Zhao, Sheila Flavahan, Susan W Leung, Aimin Xu, Paul M Vanhoutte, Nicholas A Flavahan

Abstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Local renin-angiotensin system mediates endothelial dilator dysfunction in aging arteries.American journal of physiology. Heart and circulatory physiology · 2016
    Article
  7. Ca2+ -regulated lysosome fusion mediates angiotensin II-induced lipid raft clustering in mesenteric endothelial cells.Hypertension research : official journal of the Japanese Society of Hypertension · 2016
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Yingzi ZhaoDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland; and State Key Laboratory of Pharmaceutical Biotechnology and Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, China.
Sheila FlavahanDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland; and.
Susan W LeungState Key Laboratory of Pharmaceutical Biotechnology and Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, China.
Aimin XuState Key Laboratory of Pharmaceutical Biotechnology and Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, China.
Paul M VanhoutteState Key Laboratory of Pharmaceutical Biotechnology and Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, China.
Nicholas A FlavahanDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland; and nflavah1@jhmi.edu.
Johns Hopkins University · USUniversity of Hong Kong · HK

Funding

Impaired Endothelial Maturation and the Developmental Origin of Vascular DiseaseR01HD078639 · NICHD · JOHNS HOPKINS UNIVERSITY · PI FLAVAHAN, NICHOLAS A · 2014 to 2018
$1.7M
NICHD NIH HHS HD-078639NICHD NIH HHS R01 HD078639
6 · The paper itself

Abstract

Experiments were performed to determine whether or not acute exposure to elevated pressure would disrupt endothelium-dependent dilatation by increasing local angiotensin II (ANG II) signaling. Vasomotor responses of mouse-isolated carotid arteries were analyzed in a pressure myograph at a control transmural pressure (PTM) of 80 mmHg. Acetylcholine-induced dilatation was reduced by endothelial denudation or by inhibition of nitric oxide synthase (NG-nitro-L-arginine methyl ester, 100 μM). Transient exposure to elevated PTM (150 mmHg, 180 min) inhibited dilatation to acetylcholine but did not affect responses to the nitric oxide donor diethylamine NONOate. Elevated PTM also increased endothelial reactive oxygen species, and the pressure-induced endothelial dysfunction was prevented by the direct antioxidant and NADPH oxidase inhibitor apocynin (100 μM). The increase in endothelial reactive oxygen species in response to elevated PTM was reduced by the ANG II type 1 receptor (AT1R) antagonists losartan (3 μM) or valsartan (1 μM). Indeed, elevated PTM caused marked expression of angiotensinogen, the precursor of ANG II. Inhibition of ANG II signaling, by blocking angiotensin-converting enzyme (1 μM perindoprilat or 10 μM captopril) or blocking AT1Rs prevented the impaired response to acetylcholine in arteries exposed to 150 mmHg but did not affect dilatation to the muscarinic agonist in arteries maintained at 80 mmHg. After the inhibition of ANG II, elevated pressure no longer impaired endothelial dilatation. In arteries treated with perindoprilat to inhibit endogenous formation of the peptide, exogenous ANG II (0.3 μM, 180 min) inhibited dilatation to acetylcholine. Therefore, elevated pressure rapidly impairs endothelium-dependent dilatation by causing ANG expression and enabling ANG II-dependent activation of AT1Rs. These processes may contribute to the pathogenesis of hypertension-induced vascular dysfunction and organ injury.

Indexed as

Blood PressureSignal TransductionAcetylcholineAngiotensin-Converting Enzyme InhibitorsAngiotensin IIAngiotensin II Type 1 Receptor BlockersAnimalsCaptoprilCarotid ArteriesEndothelium, VascularHydrazinesHypertensionIndolesLosartanMaleMice1,1-diethyl-2-hydroxy-2-nitrosohydrazineAcetylcholineAngiotensin-Converting Enzyme InhibitorsAngiotensin IIAngiotensin II Type 1 Receptor BlockersCaptoprilHydrazinesIndolesLosartanNG-Nitroarginine Methyl EsterNitric OxideNitric Oxide Synthase Type IIIperindoprilatReactive Oxygen SpeciesTetrazolesValineValsartanANG II type 1 receptorsangiotensin IIendotheliumhypertension

Identifiers

PMID25485905
PMCPMC4329479
OpenAlexW2049807689

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.